Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 592 is a human protein encoded by the ZNF592 gene. It is classified as a C2H2-type zinc finger protein, a major subgroup of transcription factors distinguished by multiple tandem zinc finger motifs that facilitate interactions with DNA, RNA, or other proteins[1][2]. ZNF592 is thought to be involved in regulating gene expression, particularly genes necessary for cerebellar development[1][5]. Mutations in this gene are linked to autosomal recessive spinocerebellar ataxia and have also been associated with other syndromes such as Galloway-Mowat syndrome 1 and Seckel syndrome[1][5]. While zinc finger proteins are broadly studied as genome stability regulators and potential therapeutic targets in cancer and DNA repair contexts, there is no current evidence indicating ZNF592 is a direct therapeutic target or that any drugs specifically interact with it[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 592 (ZNF592).